These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 17298352)
41. Allergenic products standardization--the role of major allergens. Helm RM; Burks AW Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):164-73. PubMed ID: 9383906 [No Abstract] [Full Text] [Related]
48. The LOCAL Study: Local reactions do not predict local reactions in allergen immunotherapy. Calabria CW; Coop CA; Tankersley MS J Allergy Clin Immunol; 2009 Oct; 124(4):739-44. PubMed ID: 19767075 [TBL] [Abstract][Full Text] [Related]
49. [Comment on the article: Hyposensitization therapy--quo vadis?]. Kompa HE Z Hautkr; 1990 Jul; 65(7):645-6. PubMed ID: 2399755 [No Abstract] [Full Text] [Related]
50. Issues in stinging insect allergy immunotherapy: a review. Finegold I Curr Opin Allergy Clin Immunol; 2008 Aug; 8(4):343-7. PubMed ID: 18596592 [TBL] [Abstract][Full Text] [Related]
51. Current standards and future directions in immunotherapy: perspectives on challenges and opportunities for the allergist. Bernstein DI; Blaiss MS; Cox LS; Finegold I; Lanier BQ; Nelson HS; Wallace DV Ann Allergy Asthma Immunol; 2011 Nov; 107(5):422-5. PubMed ID: 22018613 [No Abstract] [Full Text] [Related]
52. Relief for patients with severe allergies. Putman H; May KR RN; 2001 Jun; 64(6):26-30; quiz 31. PubMed ID: 12032929 [TBL] [Abstract][Full Text] [Related]
53. Unproven and controversial forms of immunotherapy. Terr AI; Tcheurekdjian H Clin Allergy Immunol; 2008; 21():447-53. PubMed ID: 18828522 [No Abstract] [Full Text] [Related]
54. [Status of allergen immunotherapy in the treatment of allergic diseases]. Okano M Arerugi; 2006 Jan; 55(1):22-7. PubMed ID: 16671327 [No Abstract] [Full Text] [Related]
55. Recombinant allergen-based concepts for diagnosis and therapy of type I allergy. Valenta R Allergy; 2002; 57 Suppl 71():66-7. PubMed ID: 12173274 [No Abstract] [Full Text] [Related]
56. Advantages and disadvantages of accelerated immunotherapy schedules. Cox L J Allergy Clin Immunol; 2008 Aug; 122(2):432-4. PubMed ID: 18619664 [No Abstract] [Full Text] [Related]
57. [Allergen extracts. New principles and time indicated products]. Aas K Tidsskr Nor Laegeforen; 1977 Dec; 97(34-36):1809-11. PubMed ID: 594989 [No Abstract] [Full Text] [Related]
58. Allergen immunotherapy in historical perspective. Cohen SG; Richard E Clin Allergy Immunol; 2008; 21():1-29. PubMed ID: 18828495 [No Abstract] [Full Text] [Related]